Condensed Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023		57,910,461
Beginning balance at Dec. 31, 2023	$ 266,973	$ 6	$ 489,453	$ (222,798)	$ 312
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for restricted stock units, net of shares withheld for taxes (in shares)		101,071
Issuance of common stock for restricted stock units, net of shares withheld for taxes	(32)		(32)
Issuance of common stock for cash, net of issuance costs (in shares)		2,068,246
Issuance of common stock for cash, net of issuance costs	7,938		7,938
Unrealized gain (loss) on marketable securities	(456)				(456)
Stock-based compensation	2,484		2,484
Net loss	(14,873)			(14,873)
Ending balance (in shares) at Mar. 31, 2024		60,079,778
Ending balance at Mar. 31, 2024	$ 262,034	$ 6	499,843	(237,671)	(144)
Beginning balance (in shares) at Dec. 31, 2024	60,094,083	60,094,083
Beginning balance at Dec. 31, 2024	$ 181,816	$ 6	506,985	(325,127)	(48)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for restricted stock units, net of shares withheld for taxes (in shares)		446,756
Issuance of common stock for restricted stock units, net of shares withheld for taxes	$ (73)		(73)
Stock options exercised for cash (in shares)	32,586	32,586
Stock options exercised for cash	$ 37		37
Unrealized gain (loss) on marketable securities	63				63
Stock-based compensation	2,474		2,474
Net loss	$ (28,796)			(28,796)
Ending balance (in shares) at Mar. 31, 2025	60,573,425	60,573,425
Ending balance at Mar. 31, 2025	$ 155,521	$ 6	$ 509,423	$ (353,923)	$ 15